Coupling Different Periodic Building Units for Intergrowth Zeolites.

Multiple-phase disordered zeolites, i.e., intergrowth zeolites, are important industrial catalysts, like single-phase ordered zeolites, but little is known about their rational synthesis and phase competition, mainly due to current poor understanding of the zeolite crystallization mechanism. Here, we theoretically demonstrated that sodalite and cancrinite cage layers, the periodic building units (PerBUs) of FAU/EMT and SBT/SBS structures, respectively, could be nondefectively connected to each other across double rings of 6 tetrahedral atoms when inverted and mirrored. We then synthesized an unprecedented family of FAU/SBT/SBS intergrowths with controllable FAU portions (named as the PST-34 family of intergrowth zeolites) using a multiple inorganic cation approach, providing clear experimental evidence for the layer-by-layer crystal growth mechanism of zeolites. This study shows that control of interactive cooperation extent between different inorganic structure-directing agents in the presence of an unselective organic structure-directing agent may enable repeated stacking of different but structurally related PerBUs in intergrowth zeolite synthesis.

One-Pot Synthesis of CHA/ERI-Type Zeolite Intergrowth from a Single Multiselective Organic Structure-Directing Agent.

We report the one-pot synthesis of a chabazite (CHA)/erionite (ERI)-type zeolite intergrowth structure characterized by adjustable extents of intergrowth enrichment and Si/Al molar ratios. This method utilizes readily synthesizable 6-azaspiro[5.6]dodecan-6-ium as the exclusive organic structure-directing agent (OSDA) within a potassium-dominant environment. High-throughput simulations were used to accurately determine the templating energy and molecular shape, facilitating the selection of an optimally biselective OSDA from among thousands of prospective candidates. The coexistence of the crystal phases, forming a distinct structure comprising disk-like CHA regions bridged by ERI-rich pillars, was corroborated via rigorous powder X-ray diffraction and integrated differential-phase contrast scanning transmission electron microscopy (iDPC S/TEM) analyses. iDPC S/TEM imaging further revealed the presence of single offretite layers dispersed within the ERI phase. The ratio of crystal phases between CHA and ERI in this type of intergrowth could be varied systematically by changing both the OSDA/Si and K/Si ratios. Two intergrown zeolite samples with different Si/Al molar ratios were tested for the selective catalytic reduction (SCR) of NOx with NH3, showing competitive catalytic performance and hydrothermal stability compared to that of the industry-standard commercial NH3-SCR catalyst, Cu-SSZ-13, prevalent in automotive applications. Collectively, this work underscores the potential of our approach for the synthesis and optimization of adjustable intergrown zeolite structures, offering competitive alternatives for key industrial processes.

Synthesis and Crystal Growth Mechanism of PST-2: An Aluminosilicate SBS/SBT Zeolite Intergrowth.

The synthesis of PST-2, an aluminosilicate zeolite intergrowth of cage-based, large-pore SBS and SBT topologies, and its intergrowth characteristics are presented. With the Si/Al ratio and crystallization inorganic structure-directing agent in zeolite synthesis mixtures fixed to 8.0 and Cs+ ions, respectively, pure PST-2 is obtained at 120 °C using tetraalkylammonium ions with C/N+ ratios of 5-9 as a charge density mismatch (CDM) organic structure-directing agent (OSDA). More interestingly, the intergrowth ratio between SBS and SBT in PST-2 was found to vary notably not only with the type of CDM OSDA employed but also with the crystallization time, unlike the case of other well-known zeolite intergrowths such as ß and MFI/MEL. When tetraethylammonium ions are used as a CDM OSDA at 100 °C in the presence of Cs+, the SBS portion in PST-2 decreases from over 60% to less than 45% with increasing crystallization time from 2.5 to 14 days, suggesting that SBS formation is kinetically more favorable than SBT formation. A thorough characterization of changes in the crystallite dimension of PST-2 with crystallization time, together with those in the chemical composition, allowed us to propose a plausible crystal growth mechanism of this large-pore zeolite intergrowth.

Synthesis of thermally stable SBT and SBS/SBT intergrowth zeolites.

UCSB-6 (framework type SBS) and UCSB-10 (SBT), two three-dimensional phosphate-based molecular sieves with supercages accessible through 12-ring (circumscribed by 12 tetrahedral atoms) windows, are structurally similar to the hexagonal and cubic polytypes of faujasite or zeolite Y, an industrially relevant catalyst, but the cage structures are substantially different. Nonetheless, their inherent thermal instability has precluded any catalytic application so far. By using multiple inorganic cation and charge density mismatch approaches, we synthesized PST-32 and PST-2, a thermally stable aluminosilicate version of UCSB-10 and the hypothetical SBS/SBT intergrowth family member, respectively. This study suggests that many hypothetical cage-based zeolite structures with multidimensional channel systems can be synthesized as compositionally robust forms by systematically exploring the synergy effect of inorganic and organic structure-directing agents.

Effects of sappanchalcone on the cytoprotection and anti-inflammation via heme oxygenase-1 in human pulp and periodontal ligament cells.

Sappanchalcone has been demonstrated to possess several biological effects. However, the molecular mechanism underlying these effects is not fully understood. In this study, we examined the effects of sappanchalcone on hydrogen peroxide (H(2)O(2))-induced cytotoxicity using human dental pulp (HDP) cells, and lipopolysaccharide (LPS)-induced inflammation using human periodontal ligament (HPDL) cells. Sappanchalone concentration proportionately increased heme oxygenase (HO)-1 protein expression and enzyme activity in both HDP and HPDL cells. It also protected HDP cells from H(2)O(2)-induced cytotoxicity and reactive oxygen species production. The cytoprotective effect of sappanchalcone was nullified by HO-1 inhibitor, Tin protoporphyrin (SnPP). Sappanchalcone is seen to inhibit LPS-stimulated nitric oxide (NO), prostaglandin E(2) (PGE(2)), interlukine-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), interlukine-6 (IL-6) and interlukine-12 (IL-12) release in addition to inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression in HPDL cells. SnPP, a specific inhibitor of HO-1, partly blocked sappanchalcone mediated suppression of inflammatory mediator production, in LPS-stimulated HPDL cells. HDP and HPDL cells treated with sappanchalcone exhibited the transient activation of c-Jun NH2-terminal kinase (JNK) and NF-E2-related factor-2 (Nrf2). The expression of HO-1 protein by sappanchalcone was significantly reduced by pretreatment with JNK inhibitor. In conclusion, induction of HO-1 is an important cytoprotective mechanism by which sappanchalcone protects HDP cells from H(2)O(2) and in addition it also exhibits anti-inflammatory effects in LPS-stimulated HPDL cells. Thus, sappanchalcone could potentially be a therapeutic approach for periodontal, pulpal and periapical inflammatory lesion.

The role of intestinal microflora on daidzein excretion in urine in humans treated with Chungpesagantang.

This study examined the relationship between the metabolism of the constituents of herbal medicines by human intestinal microflora and the level of metabolites excreted in the urine. This was performed by administering Chungpesagantang (CST) to volunteers and measuring their fecal metabolic activity CST to and urine excretion of daidzein, one of the metabolite of CST The metabolic activity of of CST dadizein was 54.8 +/- 16.7 mmol/h/g wet feces. When CST was administered orally to the subjects, the amount of daidzein excreted in the urine over 24 h was 103.7 +/- 55.8 mg, which accounted for 20.2% of the puerarin, daidzin and daidzein contained in CST. However, neither puerarin nor daidzin were excreted in the urine. The profile of daidzein excreted in the urine was found to be in proportion to that of the metabolic activity of the CST components. This suggests that the daidzein level excreted in the urine of the subjects administered CST is associated with the daidzein glycoside-hydrolyzing activity of the fecal microflora.